Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to evaluate the feasibility of intranasal ketamine for adequate sedation of children undergoing minor procedures in the Emergency Department. An intranasal dose of 10mg/kg will be used in patients requiring procedural sedation. The investigators hypothesize that this dose of intranasal ketamine will be able to provide adequate sedation and analgesia for the physician to successfully complete the planned diagnostic or therapeutic intervention (Pediatr Emer Care 2012;28: 767-70). The primary endpoint will be successful sedation, as defined by the ability to complete the planned procedure without rescue medication, which includes re-dosing of the same medication.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Children ages 2 years to 7 years who present as patients to the Pediatric Emergency Department at Banner University Medical Center Tucson Campus
- Body weight of 20kg or less (actual, estimated, or measured)
- NPO for four hours or more
- Undergoing various procedures, which are deemed by the treating provider to require procedural sedation for the completion of the procedure.
Exclusion criteria
- Discretion of parents
- Discretion of provider
- Body weight greater than 20kg (actual, estimated, or measured)
- Starting Aldrete score <9/10
- Known or suspected psychosis
- Known or suspected central nervous system mass, abnormalities, hydrocephalus, or other condition that would suggest elevated pre-anesthetic cerebrospinal fluid pressure
- Significant elevation in blood pressure
- Known hypersensitivity to ketamine
- Non-English or Spanish speaking
Trial design
Primary purpose
Allocation
Interventional model
Masking
10 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal